View in EDS HTML Full Text PDF Full Text

Killer‐cell immunoglobulin‐like receptor polymorphism is associated with COVID‐19 outcome: Results of a pilot observational study.

Saved in:
Bibliographic Details
Title: Killer‐cell immunoglobulin‐like receptor polymorphism is associated with COVID‐19 outcome: Results of a pilot observational study.
Authors: Niño‐Ramírez, J. E.1 (AUTHOR), Alcoceba, M.1 (AUTHOR), Gutiérrez‐Zufiaurre, M. N.2 (AUTHOR), Marcos, M.3 (AUTHOR), Gil‐Etayo, F. J.1 (AUTHOR), Bartol‐Sánchez, M. R.4 (AUTHOR), Eiros, R.5 (AUTHOR), Chillón, M. C.1 (AUTHOR), García‐Álvarez, M.1 (AUTHOR), Terradillos‐Sánchez, P.1 (AUTHOR), Presa, D.1 (AUTHOR), Muñoz, J. L.2 (AUTHOR), López‐Bernús, A.3 (AUTHOR), López‐Sánchez, E.3 (AUTHOR), González‐Calle, D.5 (AUTHOR), Sánchez, P. L.5 (AUTHOR), Compán‐Fernández, O.6 (AUTHOR), González, M.1 (AUTHOR), García‐Sanz, R.1 (AUTHOR), Boix, F.1 (AUTHOR) boix_fragin@gva.es
Source: HLA: Immune Response Genetics. Aug2024, Vol. 104 Issue 2, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20592302
DOI:10.1111/tan.15640